BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
DRS
Leonardo DRS, Inc.
DRS has the edge over BA overall, supported by stronger modeled upside and stronger valuation.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
DRS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
DRS's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over DRS in the historical PE scenario, which offers more potential upside but is not a forecast.
DRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9x | $12.28 | -66% |
| Forward | 24x | $35.66 | — |
| Current | 26x | $35.66 | — |
| Fair | 27x | $36.60 | +2.6% |
| Expensive | 43x | $58.75 | +65% |
Historical ranges are pointers, not guarantees.
DRS's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
DRS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for DRS, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
DRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.47 | +8.4% |
| Q3 2026 | $1.36 | +37% |
| Q2 2026 | $1.19 | +27% |
| Q1 2026 | $1.07 | +22% |
| Q4 2025 | $1.03 | +29% |
| Q3 2025 | $0.99 | +34% |
| Q2 2025 | $0.94 | +32% |
| Q1 2025 | $0.88 | +26% |
| Q4 2024 | $0.80 | +25% |
DRS has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
DRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +11% |
| Q2 2026 | $913M | +10% |
| Q1 2026 | $846M | +5.9% |
| Q4 2025 | $1.1B | +8.1% |
| Q3 2025 | $960M | +18% |
| Q2 2025 | $829M | +10% |
| Q1 2025 | $799M | +16% |
| Q4 2024 | $981M | +5.9% |
DRS's revenue has grown year over year for 14 quarters in a row: $1.1B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +1.2 points |
| Q2 2026 | 11% | +2.7 points |
| Q1 2026 | 9.1% | +1.7 points |
| Q4 2025 | 12% | -0.3 points |
| Q3 2025 | 9.7% | +0.4 points |
| Q2 2025 | 8.4% | +1.1 points |
| Q1 2025 | 7.4% | +1.1 points |
| Q4 2024 | 12% | +0.9 points |
DRS has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over DRS on cash flow, with more consistent year-over-year improvement.
DRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58M | -25% |
| Q2 2026 | $6M | +$62M |
| Q1 2026 | -$96M | +$74M |
| Q4 2025 | $376M | -9.2% |
| Q3 2025 | $77M | +64% |
| Q2 2025 | -$56M | -$56M |
| Q1 2025 | -$170M | +$105M |
| Q4 2024 | $414M | -17% |
DRS generated $344M in free cash flow over the past year, up 30% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
DRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -600K shares |
| 1 year | 0% | -100K shares |
| 3 years | +1.2% | +3.3M shares |
| 5 years | +85% | +123M shares |
| Available history | +85% | +123M shares |
DRS has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $12M |
| Q2 2026 | $12M |
| Q1 2026 | $4M |
| Q4 2025 | $11M |
| Q3 2025 | $10M |
| Q2 2025 | $11M |
| Q1 2025 | $3M |
| Q4 2024 | $15M |
DRS spent $39M buying back its own shares over the past year, about the same as the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
DRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
DRS has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
DRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 21.1 | Neutral |
DRS's weekly RSI is 42 (neutral) and its Stochastic is 21 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over DRS on valuation relative to its sector.
DRS PE vs Industrials Sector
| Metric | DRS | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 9.1% above |
| PE % | 49 | 58 | 9 pts below |
DRS is trading at 26x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
DRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.9 | 0.8% below |
| 20 week MA | $39.7 | 10% below |
| 50 week MA | $41.0 | 13% below |
| 100 week MA | $39.8 | 10% below |
| 200 week MA | $30.4 | 17% above |
DRS has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
DRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.35 | $10.3 | +92% |
| 2021 | $10.3 | $9.45 | -8% |
| 2022 | $9.45 | $13.2 | +39% |
| 2023 | $13.2 | $20.0 | +52% |
| 2024 | $20.0 | $32.5 | +62% |
| 2025 | $32.5 | $34.3 | +5.3% |
| 2026 YTD | $34.3 | $35.7 | +4% |
DRS has the edge over BA on returns for 2026, with the stronger performance.